Harrow Health
American pharmaceutical company
HROW Nasdaq
SEC CIK 1360214
Follow Harrow Health
Weekly email: filings, results
Revenue, last quarter
$99.3M
+38.6% vs same quarter last year
Net income
$9.8M
+856.6% vs same quarter last year
EPS, diluted
$0.25
+733.3% vs same quarter last year
Operating cash flow
−$8.6M
−151.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $272.3M | −$5.1M |
| FY24 | $199.6M | −$17.5M |
| FY23 | $130.2M | −$24.4M |
| FY22 | $88.6M | −$14.1M |
| FY21 | $72.5M | −$18M |
| FY20 | $48.9M | −$3.4M |
| FY19 | $51.2M | $168K |
| FY18 | $41.4M | $14.6M |
| FY17 | $26.8M | −$12M |
| FY16 | $19.9M | −$19.1M |
| FY15 | $9.7M | −$15.9M |
| FY14 | $1.7M | −$10.1M |
| FY13 | $10K | −$7.6M |
| FY12 | - | −$5.4M |
| FY11 | - | −$953.9K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 75.1% | 11.2% | −1.9% |
| FY24 | 75.3% | 4.4% | −8.8% |
| FY23 | 69.6% | 0.3% | −18.7% |
| FY22 | 71.3% | 2.2% | −15.9% |
| FY21 | 74.9% | 2.2% | −24.8% |
| FY20 | 70.4% | 0.8% | −6.9% |
| FY19 | 67.3% | −9.4% | 0.3% |
| FY18 | 60.1% | −12.6% | 35.3% |
| FY17 | 49.6% | −45.4% | −44.8% |
| FY16 | 50.7% | −79.6% | −95.7% |
| FY15 | 46.4% | −152.6% | −163.6% |
| FY14 | 34.2% | −611.3% | −609.5% |
| FY13 | 100% | −76868.8% | −76431.2% |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $43M |
| FY24 | −$23.8M |
| FY23 | $2.4M |
| FY22 | −$892K |
| FY21 | $3.3M |
| FY20 | −$2M |
| FY19 | −$518K |
| FY18 | −$1.1M |
| FY17 | −$9.6M |
| FY16 | −$18.1M |
| FY15 | −$12.1M |
| FY14 | −$7.2M |
| FY13 | −$4.5M |
| FY12 | −$1.9M |
| FY11 | −$291.2K |
- Harrow Health
- Healthcare median
Show the numbers
| Year | Harrow Health | Healthcare median |
|---|---|---|
| FY25 | −1.9% | −30.6% |
| FY24 | −8.8% | −47% |
| FY23 | −18.7% | −58% |
| FY22 | −15.9% | −80.4% |
| FY21 | −24.8% | −71.9% |
| FY20 | −6.9% | −62.2% |
| FY19 | 0.3% | −46.3% |
| FY18 | 35.3% | −49.6% |
| FY17 | −44.8% | −45.9% |
| FY16 | −95.7% | −36% |
| FY15 | −163.6% | −38.4% |
| FY14 | −609.5% | −35.5% |
| FY13 | −76431.2% | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |